Biotechnology company.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Altimmune in the last 30 days yet.
The 1 sources with the most insights about Altimmune on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
The speaker has a very negative initial impression of the company's recent 'positive top line results,' calling them 'Dog poo-poo,' but admits he has not yet looked at the data in detail.
The speaker has a very negative initial impression of the company's recent 'positive top line results,' calling them 'Dog poo-poo,' but admits he has not yet looked at the data in detail.
Other assets that creators frequently mention in the same content as Altimmune.
The most active sources covering Altimmune (ALT) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about Altimmune (ALT) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Altimmune (ALT) most frequently also discuss BBAI, QBTS, MDGL, INMB, NKTR. See the "Discussed alongside" section above for full asset pages.